Saniona AB (SANION) - Net Assets
Based on the latest financial reports, Saniona AB (SANION) has net assets worth Skr635.16 Million SEK (≈ $68.35 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr679.74 Million ≈ $73.15 Million USD) and total liabilities (Skr44.58 Million ≈ $4.80 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Saniona AB liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr635.16 Million |
| % of Total Assets | 93.44% |
| Annual Growth Rate | N/A |
| 5-Year Change | 125.23% |
| 10-Year Change | 1070.76% |
| Growth Volatility | 478.38 |
Saniona AB - Net Assets Trend (2012–2025)
This chart illustrates how Saniona AB's net assets have evolved over time, based on quarterly financial data. Also explore Saniona AB balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for Saniona AB (2012–2025)
The table below shows the annual net assets of Saniona AB from 2012 to 2025. For live valuation and market cap data, see SANION company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr635.16 Million ≈ $68.35 Million |
+173.99% |
| 2024-12-31 | Skr231.82 Million ≈ $24.95 Million |
+1156.60% |
| 2023-12-31 | Skr-21.94 Million ≈ $-2.36 Million |
-141.63% |
| 2022-12-31 | Skr52.71 Million ≈ $5.67 Million |
-81.31% |
| 2021-12-31 | Skr282.00 Million ≈ $30.35 Million |
-53.27% |
| 2020-12-31 | Skr603.46 Million ≈ $64.94 Million |
+932.66% |
| 2019-12-31 | Skr58.44 Million ≈ $6.29 Million |
+48.10% |
| 2018-12-31 | Skr39.46 Million ≈ $4.25 Million |
+4.86% |
| 2017-12-31 | Skr37.63 Million ≈ $4.05 Million |
-30.64% |
| 2016-12-31 | Skr54.25 Million ≈ $5.84 Million |
+2.47% |
| 2015-12-31 | Skr52.94 Million ≈ $5.70 Million |
+502.93% |
| 2014-12-31 | Skr8.78 Million ≈ $944.98K |
+1427.13% |
| 2013-12-31 | Skr575.00K ≈ $61.88K |
+137.31% |
| 2012-12-31 | Skr-1.54 Million ≈ $-165.84K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Saniona AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 35084600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr6.90 Million | 1.09% |
| Other Comprehensive Income | Skr-19.75 Million | -3.11% |
| Other Components | Skr1.00 Billion | 157.53% |
| Total Equity | Skr635.16 Million | 100.00% |
Saniona AB Competitors by Market Cap
The table below lists competitors of Saniona AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TYM Corporation
KO:002900
|
$207.74 Million |
|
Brogent Technologies
TWO:5263
|
$207.84 Million |
|
Pitanium Ltd
NASDAQ:PTNM
|
$207.93 Million |
|
Halma PLC
LSE:HLMA
|
$208.04 Million |
|
Mayfield Group Holdings Ltd
AU:MYG
|
$207.53 Million |
|
Avalue Technology
TWO:3479
|
$207.33 Million |
|
Triplepoint Venture Growth BDC Corp
NYSE:TPVG
|
$207.31 Million |
|
Kaltura Inc
NASDAQ:KLTR
|
$207.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Saniona AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 231,818,000 to 635,159,000, a change of 403,341,000 (174.0%).
- Net income of 284,666,000 contributed positively to equity growth.
- New share issuances of 114,951,000 increased equity.
- Other comprehensive income decreased equity by 26,956,000.
- Other factors increased equity by 30,680,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr284.67 Million | +44.82% |
| Share Issuances | Skr114.95 Million | +18.1% |
| Other Comprehensive Income | Skr-26.96 Million | -4.24% |
| Other Changes | Skr30.68 Million | +4.83% |
| Total Change | Skr- | 173.99% |
Book Value vs Market Value Analysis
This analysis compares Saniona AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.91x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | Skr-0.11 | Skr13.98 | x |
| 2013-12-31 | Skr0.04 | Skr13.98 | x |
| 2014-12-31 | Skr0.65 | Skr13.98 | x |
| 2015-12-31 | Skr2.90 | Skr13.98 | x |
| 2016-12-31 | Skr2.53 | Skr13.98 | x |
| 2017-12-31 | Skr1.71 | Skr13.98 | x |
| 2018-12-31 | Skr1.77 | Skr13.98 | x |
| 2019-12-31 | Skr1.92 | Skr13.98 | x |
| 2020-12-31 | Skr12.45 | Skr13.98 | x |
| 2021-12-31 | Skr3.82 | Skr13.98 | x |
| 2022-12-31 | Skr0.71 | Skr13.98 | x |
| 2023-12-31 | Skr-0.34 | Skr13.98 | x |
| 2024-12-31 | Skr2.16 | Skr13.98 | x |
| 2025-12-31 | Skr4.80 | Skr13.98 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Saniona AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 44.82%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 65.53%
- • Asset Turnover: 0.64x
- • Equity Multiplier: 1.07x
- Recent ROE (44.82%) is above the historical average (-85.17%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 0.00% | -21.30% | 0.97x | 0.00x | Skr-1.50 Million |
| 2013 | -224.25% | -9.45% | 0.91x | 26.21x | Skr-1.35 Million |
| 2014 | -67.28% | -27.20% | 1.40x | 1.76x | Skr-6.79 Million |
| 2015 | -43.34% | -168.36% | 0.24x | 1.09x | Skr-28.24 Million |
| 2016 | 4.09% | 2.96% | 1.06x | 1.30x | Skr-3.21 Million |
| 2017 | -130.72% | -237.72% | 0.43x | 1.29x | Skr-52.95 Million |
| 2018 | -104.06% | -74.81% | 0.66x | 2.11x | Skr-45.00 Million |
| 2019 | -129.69% | -2851.32% | 0.03x | 1.64x | Skr-81.63 Million |
| 2020 | -12.17% | -895.71% | 0.01x | 1.15x | Skr-133.78 Million |
| 2021 | -145.71% | -3921.53% | 0.02x | 1.56x | Skr-439.10 Million |
| 2022 | -465.50% | -1605.42% | 0.10x | 2.92x | Skr-250.63 Million |
| 2023 | 0.00% | -568.94% | 0.26x | 0.00x | Skr-93.62 Million |
| 2024 | 81.40% | 56.39% | 0.99x | 1.47x | Skr165.52 Million |
| 2025 | 44.82% | 65.53% | 0.64x | 1.07x | Skr221.15 Million |
Industry Comparison
This section compares Saniona AB's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $181,930,027
- Average return on equity (ROE) among peers: -108.15%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Saniona AB (SANION) | Skr635.16 Million | 0.00% | 0.07x | $207.66 Million |
| 2cureX AB (2CUREX) | $8.19 Million | -5.85% | 0.47x | $4.90 Million |
| Ascelia Pharma AB (publ) (ACE) | $236.06 Million | -41.81% | 0.08x | $40.96 Million |
| AcouSort AB (ACOU) | $5.92 Million | -163.51% | 0.36x | $8.97 Million |
| Active Biotech AB (ACTI) | $30.67 Million | -149.35% | 0.44x | $17.19 Million |
| Alzinova AB (ALZ) | $947.42K | -195.83% | 0.18x | $4.97 Million |
| AlzeCure Pharma (ALZCUR) | $32.97 Million | -235.89% | 0.38x | $18.18 Million |
| Annexin Pharmaceuticals AB (ANNX) | $18.81 Million | -234.16% | 0.42x | $11.24 Million |
| Alligator Bioscience AB (ATORX) | $115.24 Million | -124.61% | 0.32x | $14.33 Million |
| BioInvent International AB (BINV) | $1.31 Billion | -25.22% | 0.07x | $155.44 Million |
| BioArctic AB (publ) (BIOA-B) | $60.76 Million | 94.77% | 10.65x | $2.59 Billion |
About Saniona AB
Saniona AB (publ), a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom. It also develops medicines modulating ion channels. The company's product includes Tesofensine, a monoamine reuptake inhibitor that has completed Phase 3 clinical t… Read more